Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02845440 · ClinicalTrials.gov registry record · NA
Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,165
- Enrollment target
NCT02845440: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02845440 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02845440, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,165 participants
- Enrollment target
Study Summary
The overall aim of this study is to test the effect of academic detailing (i.e. provider-level educational intervention focused on evidence-based smoking cessation treatment for those with psychiatric illness) and community health worker (CHW) support on the provision and utilization of standard of care smoking cessation treatment to those with serious mental illness (SMI) and smoking cessation rates for adults with SMI who smoke.
Interventions
- OTHER Treatment as Usual (TAU)
- OTHER Community Health Worker
- OTHER Academic Detailing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,165 participants |
| Start Date | 2016-07-14 |
| Est. Completion | 2021-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02845440
The ClinicalTrials.gov registry entry for NCT02845440 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT02845440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02845440 about?
NCT02845440 is a clinical study titled "Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness". The overall aim of this study is to test the effect of academic detailing (i.e. provider-level educational intervention focused on evidence-based smoking cessation treatment for those with psychiatric illness) and community health worker (CHW) support on the provision and utilization of standard of ...
What is the current status of trial NCT02845440?
This trial is currently completed. It is a NA study. The enrollment target is 1,165 participants. The study started on 2016-07-14. Estimated completion is 2021-01-12.
What interventions are being tested in trial NCT02845440?
The interventions under investigation include: Treatment as Usual (TAU) (OTHER), Community Health Worker (OTHER), Academic Detailing (OTHER).
Who is sponsoring clinical trial NCT02845440?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.